Jeremy DeMartini1, Joshua J Fenton2, Ronald Epstein3, Paul Duberstein4, Camille Cipri5, Daniel Tancredi6, Guibo Xing5, Paul Kaesberg7, Richard L Kravitz8. 1. Department of Psychiatry, University of California, Davis, Sacramento, California, USA. Electronic address: jmdemartini@ucdavis.edu. 2. Department of Family and Community Medicine, University of California, Davis, Sacramento, California, USA; Center for Healthcare Policy and Research, University of California, Davis, Sacramento, California, USA. 3. Department of Family Medicine, University of Rochester, Rochester, New York, USA; Department of Psychiatry, University of Rochester, Rochester, New York, USA; Wilmot Cancer Center, University of Rochester, Rochester, New York, USA; Department of Medicine, University of Rochester, Rochester, New York, USA. 4. Department of Family Medicine, University of Rochester, Rochester, New York, USA; Department of Psychiatry, University of Rochester, Rochester, New York, USA. 5. Center for Healthcare Policy and Research, University of California, Davis, Sacramento, California, USA. 6. Department of Pediatrics, University of California, Davis, Sacramento, California, USA. 7. Division of Hematology and Oncology, University of California, Davis, Sacramento, California, USA. 8. Division of General Medicine, University of California, Davis, Sacramento, California, USA; Center for Healthcare Policy and Research, University of California, Davis, Sacramento, California, USA.
Abstract
CONTEXT: Little is known about the hopes patients with advanced (incurable) cancer have for their treatment. OBJECTIVES: The objective of this study was to describe the treatment hopes of advanced cancer patients, factors associated with expressing specific hopes, and the persons with whom hopes are discussed. METHODS: We surveyed 265 advanced cancer patients in the U.S. about their hopes for treatment at the baseline and after three months. We developed a taxonomy of hopes for treatment, which two investigators used to independently code patient responses. We explored associations between hopes for cure and patient covariates. RESULTS: We developed eight categories of hopes. We were able to apply these codes reliably, and 95% of the patient's responses fit at least one hope category. The hope categories in order of descending baseline prevalence were as follows: quality of life, life extension, tumor stabilization, remission, milestone, unqualified cure, control not otherwise specified, and cure tempered by realism. Most patients reported discussing hopes with partners, family/friends, and oncologists; a minority reported discussing hopes with nurses, primary care physicians, clergy, or support groups. In logistic regression analysis, unqualified hopes for cure were more likely in younger patients and in those who did not endorse discussing their hopes with primary care physicians. CONCLUSION: Advanced cancer patients harbor a range of treatment hopes. These hopes often are not discussed with key members of the health care team. Younger age and lack of discussion of hopes with primary care physicians may lead to less realistic hopes for cure. Published by Elsevier Inc.
CONTEXT: Little is known about the hopes patients with advanced (incurable) cancer have for their treatment. OBJECTIVES: The objective of this study was to describe the treatment hopes of advanced cancerpatients, factors associated with expressing specific hopes, and the persons with whom hopes are discussed. METHODS: We surveyed 265 advanced cancerpatients in the U.S. about their hopes for treatment at the baseline and after three months. We developed a taxonomy of hopes for treatment, which two investigators used to independently code patient responses. We explored associations between hopes for cure and patient covariates. RESULTS: We developed eight categories of hopes. We were able to apply these codes reliably, and 95% of the patient's responses fit at least one hope category. The hope categories in order of descending baseline prevalence were as follows: quality of life, life extension, tumor stabilization, remission, milestone, unqualified cure, control not otherwise specified, and cure tempered by realism. Most patients reported discussing hopes with partners, family/friends, and oncologists; a minority reported discussing hopes with nurses, primary care physicians, clergy, or support groups. In logistic regression analysis, unqualified hopes for cure were more likely in younger patients and in those who did not endorse discussing their hopes with primary care physicians. CONCLUSION: Advanced cancerpatients harbor a range of treatment hopes. These hopes often are not discussed with key members of the health care team. Younger age and lack of discussion of hopes with primary care physicians may lead to less realistic hopes for cure. Published by Elsevier Inc.
Entities:
Keywords:
Hope; advanced cancer; communication; end-of-life care; goals; palliative care
Authors: Tyler H Haberle; Laura A Shinkunas; Zachary D Erekson; Lauris C Kaldjian Journal: Am J Hosp Palliat Care Date: 2010-11-21 Impact factor: 2.500
Authors: Lauris C Kaldjian; Ann E Curtis; Laura A Shinkunas; Katrina T Cannon Journal: Am J Hosp Palliat Care Date: 2008 Dec-2009 Jan Impact factor: 2.500
Authors: Felicitas Hitz; Karin Ribi; Qiyu Li; Dirk Klingbiel; Thomas Cerny; Dieter Koeberle Journal: Support Care Cancer Date: 2013-07-05 Impact factor: 3.603
Authors: C G Koedoot; R J de Haan; A M Stiggelbout; P F M Stalmeier; A de Graeff; P J M Bakker; J C J M de Haes Journal: Br J Cancer Date: 2003-12-15 Impact factor: 7.640
Authors: Kelly M Trevino; Holly G Prigerson; Megan Johnson Shen; Daniel J Tancredi; Guibo Xing; Michael Hoerger; Ronald M Epstein; Paul R Duberstein Journal: Cancer Date: 2019-05-30 Impact factor: 6.860
Authors: Teresa Thomas; Andrew Althouse; Lauren Sigler; Robert Arnold; Edward Chu; Douglas B White; Margaret Rosenzweig; Kenneth Smith; Thomas J Smith; Yael Schenker Journal: Psychooncology Date: 2021-03-08 Impact factor: 3.955
Authors: Evie E M Kolsteren; Esther Deuning-Smit; Alanna K Chu; Yvonne C W van der Hoeven; Judith B Prins; Winette T A van der Graaf; Carla M L van Herpen; Inge M van Oort; Sophie Lebel; Belinda Thewes; Linda Kwakkenbos; José A E Custers Journal: Cancers (Basel) Date: 2022-08-11 Impact factor: 6.575
Authors: Paul K J Han; Elizabeth Scharnetzki; Eric Anderson; John DiPalazzo; Tania D Strout; Caitlin Gutheil; F Lee Lucas; Emily Edelman; Jens Rueter Journal: J Pain Symptom Manage Date: 2021-12-22 Impact factor: 3.612